ELCC 2025: Latest in EGFR positive NSCLC
Prof Ulrik Ringborg (Karolinska Institutet) of the EurocanPlatform project explains what the most exciting achievements to come out of the project have been, including the sustainable collaboration between the research centres involved and how this will help translational cancer research in the future.
EurocanPlatform is an EC funded project bringing together 23 European cancer institutions and organisations to work together in a unique collaboration. The centres are sharing infrastructures and collaborating on projects to help advance cancer research and treatment.
For more information on initiatives coming out of the project, learn more about Cancer Core Europe and Cancer Prevention Europe or read the news story.
ELCC 2025: Latest in EGFR positive NSCLC
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
OncoAlert round up July 28th to August 3rd, 2023
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC